Chairman Upton: “Instead of holding on to outmoded laws and regulations, we need to build the new Architecture of Abundance to create jobs, power our economy, and lower prices to consumers.”
OPINION: Rep. Fred Upton in Reuters: "The Architecture of Abundance: Building Energy Infrastructure"July 25, 2013 | ICYMI
WASHINGTON, DC – The Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), today examined the Department of Energy’s management structure and efforts underway at the agency to improve project management and mission performance.
WASHINGTON, DC – The Subcommittee on Energy and Power today wrapped up its two-day hearing on “Overview of the Renewable Fuel Standard (RFS): Stakeholder Perspectives.” The hearing continued the committee’s bipartisan oversight of the RFS, following the release of a series of bipartisan white papers and a previous subcommittee
Subcommittee Examines Obstacles Surrounding Negotiation of the Transatlantic Trade and Investment PartnershipJuly 24, 2013 | Press Release
WASHINGTON, DC – The Subcommittee on Commerce, Manufacturing, and Trade, chaired by Rep. Lee Terry (R-NE), today held a hearing on “The U.S. - E.U. Free Trade Agreement: Tipping Over the Regulatory Barriers?” The hearing explored the issues surrounding the negotiation of the Transatlantic Trade and Investment Partnership, or T-TIP.
WASHINGTON, DC – House Energy and Commerce leaders from the Health and Oversight and Investigations Subcommittees today sent a letter to the President and Chief Executive Office of Smithfield Foods, Inc., C.
Excerpt: The contamination of the U.S. heparin supply has been linked by the FDA and other authorities to intentional adulteration during the manufacture of heparin in China. … The committee’s investigation indicates that the U.S. heparin supply is stressed, and could well be in shortage. China’s heparin market is experiencing its own pressures, and Smithfield Foods under Shuanghui control may be pressured to export its crude heparin product to China instead of supplying U.S. companies.